Pharmasight
Sign inSee a worked packBook the bench
Build · Certara

Transformed study metadata management with Pinnacle 21 Enterprise

BiogenBuildCertaraPinnacle 21

Biogen transformed study metadata management with Pinnacle 21 Enterprise. Named alongside Certara in Certara’s own account of this story: Pinnacle 21.

Certara is a biosimulation software company (Simcyp, Phoenix) whose PK/PD and QSP models predict drug behavior in the body; the FDA itself licenses Certara's software to review sponsor submissions.

This sits in the Build stage of the AI use-case lifecycle: Named examples from the foundation-model labs and platforms pharma teams use to actually construct, train and generate the model or application.

Source

Published by Certara on its own site — read the original case study on certara.com ↗

More like this

Related use cases

  1. 01Cut QC time for regulatory submissions from hours to minutes using GlobalSubmitPrelude TherapeuticsCertaraBuild
  2. 02Shortened design-make-test-analyze discovery cycle using D360ArvinasCertaraBuild
  3. 03Enhanced pharmacokinetics workflows with a cloud-based PK solutionCharles River LaboratoriesCertaraBuild
  4. 04Standardized real-world rare-disease data for FDA complianceATHNCertaraBuild
  5. 05Fast-tracked FDA approval of sunvozertinib for NSCLC via pharmacometricsDizal PharmaceuticalCertaraBuild
  6. 06Communicated clinical/economic value using BaseCase interactive apps (Abilify MaintenaOtsukaCertaraBuild